Benchmarking and Transparency: Incentives for the Pharmaceutical Industry’s Corporate Social Responsibility

Lee, Matthew; Köhler, Jillian Clare

doi:10.1007/s10551-010-0444-y

Cited by 46 publications

(36 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Driscoll and Crombie (2001), Lee and Kohler (2010) and Beelitz and Merkl-Davies (2012) are examples of studies of the use of language in inter-party conflicts.…”

Section: Verbal Interaction Between Organisations and Their Audiencesmentioning

confidence: 99%

Dialogism in Corporate Social Responsibility Communications: Conceptualising Verbal Interaction Between Organisations and Their Audiences

2013

View full text Add to dashboard Cite

We conceptualise CSR communication as a process of reciprocal influence between organisations and their audiences. We use an illustrative case study in the form of a conflict between firms and a powerful stakeholder which is played out in a series of 20 press releases over a two-month period to develop a framework of analysis based on insights from linguistics. It focuses on three aspects of dialogism, namely (i) turn-taking (co-operating in a conversation by responding to the other party), (ii) inter-party moves (the nature and type of interaction action characterising a turn i.e., denial, apology, excuse), and (iii) intertextuality (the intensity and quality of verbal interaction between the parties). We address the question:What is the nature and type of verbal interactions between the parties? First we examine (a) whether the parties verbally interact and then (b) whether the parties listen to each other.We find evidence of dialogism suggesting that CSR communication is an interactive process which has to be understood as a function of the power relations between a firm and a specific stakeholder. Also, we find evidence of intertextuality in the press releases by the six firms which engage in verbal interaction with the stakeholder. We interpret this as linguistic evidence of isomorphic processes relating to CSR practices resulting from the pressure exerted by a powerful stakeholder. The lack of response by ten firms that fail to issue press releases suggests a strategy of 'watch-and-wait' with respect to the outcome of the conflict.

show abstract

“…Driscoll and Crombie (2001), Lee and Kohler (2010) and Beelitz and Merkl-Davies (2012) are examples of studies of the use of language in inter-party conflicts.…”

Section: Verbal Interaction Between Organisations and Their Audiencesmentioning

confidence: 99%

Dialogism in Corporate Social Responsibility Communications: Conceptualising Verbal Interaction Between Organisations and Their Audiences

2013

View full text Add to dashboard Cite

show abstract

“…It enables a corporate to use the knowledge and experience of others to further improve performance (Lankford, 2000), so as to better "monitor changes in the industry, predict the emergence of new technologies, and observe the implementation of new management practices such as corporate social responsibility" (Parast and Adams, 2012). Benchmarking activities can create a competitive environment within an industry, which would facilitate the implementation of CSR practices (Lee and Kohler, 2010).…”

Section: Introductionmentioning

confidence: 99%

Perception of corporate social responsibility: the case of Chinese international contractors

Fang

Xue

et al. 2015

Journal of Cleaner Production

View full text Add to dashboard Cite

“…CSR in the pharmaceutical industry and the reporting of CSR initiatives has been only marginally explored by research (Lee & Kohler, 2010;Sweeney & Coughlan, 2008). There is therefore a lack of literature about how pharmaceutical companies report the social and environmental impact of their activities to stakeholders (Sweeney & Coughlan, 2008).…”

Section: Social Responsibilities Of Pharmaceutical Companiesmentioning

confidence: 99%

Digital Reflections of Pharmaceutical Companies and their CSR Communication Strategies

Grigore¹,

Adi²,

Theofilou³

2015

Developments in Corporate Governance and Responsibility

View full text Add to dashboard Cite

Purpose À Taking into consideration that the number of reports about pharmaceutical lobbying activities is increasing (Baleta, 2014;Boseley, 2014) and that the cost of drugs has a direct and powerful impact on both public and private healthcare, there is a need to require pharmaceutical companies to report their activity as well as reflect their considerations about the ethical implications of their work. To answer that need, this chapter explores how pharmaceutical companies communicate their corporate social responsibility activities.Methodology/approach À This chapter explores how Pfizer, GlaxoSmithKline and Sanofi (all in the top 10 of US foundations by total giving) use their websites to articulate their CSR strategies. In order to achieve this goal, an exploratory research that combines Corporate Social Responsibility in the Digital Age Developments in Corporate Governance and Responsibility, Volume 7, 221À239Practical implications and originality/value À This chapter promotes an alternative exploratory method of online discourses through computeraided techniques.

show abstract

Benchmarking and Transparency: Incentives for the Pharmaceutical Industry’s Corporate Social Responsibility

Abstract: benchmarking, corporate social respon- sibility, pharmaceutical industry, socially responsible investing, transparency,

Cited by 46 publications

References 37 publications

Dialogism in Corporate Social Responsibility Communications: Conceptualising Verbal Interaction Between Organisations and Their Audiences

Dialogism in Corporate Social Responsibility Communications: Conceptualising Verbal Interaction Between Organisations and Their Audiences

Perception of corporate social responsibility: the case of Chinese international contractors

Digital Reflections of Pharmaceutical Companies and their CSR Communication Strategies

Contact Info

Product

Resources

About